Personalized medicine: importance of clinical interpretative skills for real-world patient care

被引:0
|
作者
Gryn, Steven E. [1 ]
Kim, Richard B. [1 ]
机构
[1] Univ Western Ontario, Div Clin Pharmacol, Dept Med, London Hlth Sci Centre UH, London, ON N6A 5A5, Canada
基金
加拿大健康研究院;
关键词
azathioprine; clinical pharmacology; clopidogrel; metoprolol; pharmacogenetics; pharmacogenomics; statin; warfarin; IMPLEMENTATION CONSORTIUM GUIDELINES; PERCUTANEOUS CORONARY INTERVENTION; CYP2C19; GENOTYPE; BREAST-CANCER; COST-EFFECTIVENESS; ACTIVE METABOLITE; CYP2D6; CARDIOVASCULAR OUTCOMES; ANTIPLATELET THERAPY; PLATELET REACTIVITY;
D O I
10.2217/PME.14.16
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sequencing of the human genome led to great hopes and expectations for a 'genomics revolution' where disease diagnosis as well as therapies would be based on an individual's genetic makeup. Although significant progress has been made, a number of challenging hurdles must be overcome prior to the broader adoption and implementation of pharmacogenomics and personalized medicine as a part of standard patient care. One aspect of pharmacogenomics-based personalized medicine that has not garnered as much attention, a key focus of this perspective, is the importance of interpreting pharmacogenomic test results in a patient-specific clinical context, and expert physicians and other allied health care providers with the requisite expertise in clinical pharmacology and genomics who are able to provide such services.
引用
收藏
页码:395 / 408
页数:14
相关论文
共 50 条
  • [1] The importance of real-world data to precision medicine
    Kalra, Dipak
    [J]. PERSONALIZED MEDICINE, 2019, 16 (02) : 79 - 82
  • [2] Clinical trials and "real-world" medicine
    Simes, RJ
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (08) : 410 - 411
  • [3] Economic evaluation of personalized medicine: a call for real-world data
    Terkola, Robert
    Antonanzas, Fernando
    Postma, Maarten
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2017, 18 (09): : 1065 - 1067
  • [4] Economic evaluation of personalized medicine: a call for real-world data
    Robert Terkola
    Fernando Antoñanzas
    Maarten Postma
    [J]. The European Journal of Health Economics, 2017, 18 : 1065 - 1067
  • [5] Real-world research and its importance in respiratory medicine
    Price, David
    Brusselle, Guy
    Roche, Nicolas
    Freeman, Daryl
    Chisholm, Alison
    [J]. BREATHE, 2015, 11 (01) : 26 - 38
  • [6] Clinical care: Real-world data
    Stewart, Z. A.
    Meek, C. L.
    Yamamoto, J.
    Furse, S.
    Feig, D.
    Koulman, A.
    Murphy, H. R.
    [J]. DIABETIC MEDICINE, 2020, 37 : 7 - 8
  • [7] Clinical Trials to "Real-World" Heart Failure: Applying Risk Stratification to Deliver Personalized Care
    Baliga, Ragavendra R.
    Young, James B.
    [J]. HEART FAILURE CLINICS, 2011, 7 (04) : XI - XIV
  • [8] The impact of precision medicine on real-world clinical care: A single institution retrospective study
    Patel, Rajvi
    Quinn, Ryann
    Zhu, Xinhua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [9] The personalized medicine challenge: shifting to population health through real-world data
    Mc Cord, Kimberly Alba
    [J]. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2019, 64 (09) : 1255 - 1256
  • [10] REAL-WORLD PHARMACOGENOMICS- BASED PATIENT CARE
    Alfonsi, J.
    Kim, R.
    Teft, W.
    Dool, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S20 - S20